Recombinant human thrombopoietin promotes platelet recovery in DCAG-treated patients with intermediate-high-risk MDS/hypoproliferative AML

This study aimed to explore the effects of recombinant human thrombopoietin (rhTPO) on platelet recovery in decitabine, cytarabine, aclarubicin, and G-CSF (DCAG)-treated patients with intermediate-high-risk myelodysplastic syndrome/hypo proliferative acute myeloid leukemia. METHODS: Recruited patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xiangli, Wang, Yacai, Zang, Yuzhu, Wei, Zhenghong, Zhang, Wenhui, Wei, Xiuli, Luo, Guangli, Chen, Li, Zhang, Yin, Xu, Zhiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063278/
https://www.ncbi.nlm.nih.gov/pubmed/37000082
http://dx.doi.org/10.1097/MD.0000000000033373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063278/
https://www.ncbi.nlm.nih.gov/pubmed/37000082
http://dx.doi.org/10.1097/MD.0000000000033373

Ejemplares similares